Skip to content

Shares (Basic) at other companies

Amgen logo
AmgenAMGN
540M+0.4%
Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.3%
Exelixis logo
ExelixisEXEL
258.3M-7.3%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
162.2M+43.1%
CG Oncology logo
CG OncologyCGON
84.5M+10.9%
Lantheus Holdings logo
Lantheus HoldingsLNTH
64.7M-5.7%

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.55B+1,915%
Enterprise value$4.43B+2,204%
P/S79.9×+74.4×

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's shares (basic)?
Tango Therapeutics (TNGX) reported shares (basic) of 143.6M in Q1 2026.
How has Tango Therapeutics's shares (basic) changed year-over-year?
Tango Therapeutics's shares (basic) increased by 30.2% year-over-year, from 110.3M to 143.6M.
What is the long-term trend for Tango Therapeutics's shares (basic)?
Over 3 years (2022 to 2025), Tango Therapeutics's shares (basic) has grown at a 8.4% compound annual growth rate (CAGR), from 351.2M to 448M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.